1. 2022-LBA-746-ESGO Implementation of a comprehensive cancer genome profiling programme into clinical practice: an italian experience in a referral centre for gynecological cancers. (27th October 2022) Authors: Nero, Camilla; Pelligra, Silvia; Duranti, Simona; Giacomini, Flavia; Camarda, Floriana; Giudice, Elena; Piermattei, Alessia; Sillano, Francesca; Minucci, Angelo; de Bonis, Maria; Raspaglio, Giuseppina; Giacò, Luciano; Cordisco, Emanuela Lucci; de Donato, Marta; Pasciuto, Tina; Giannarelli, Diana;... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1638-ESGO Randomized phase III trial on Niraparib-TSR-042 (dostarlimab) versus physician's choice in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33). (20th October 2022) Authors: Salutari, Vanda; Musacchio, Lucia; Pignata, Sandro; Braicu, Elena; Cibula, David; Colombo, Nicoletta; Frenel, Jean Sebastien; Giolitto, Serena; Camarda, Floriana; Perri, Maria Teresa; Giudice, Elena; Scambia, Giovanni; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advanced and recurrent endometrial cancer: State of the art and future perspectives. (December 2022) Authors: Tronconi, Francesca; Nero, Camilla; Giudice, Elena; Salutari, Vanda; Musacchio, Lucia; Ricci, Caterina; Carbone, Maria Vittoria; Ghizzoni, Viola; Perri, Maria Teresa; Camarda, Floriana; Gentile, Marica; Berardi, Rossana; Scambia, Giovanni; Lorusso, Domenica Journal: Critical reviews in oncology/hematology Issue: Volume 180(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023) Authors: Pignata, Sandro; Scambia, Giovanni; Schettino, Clorinda; Arenare, Laura; Pisano, Carmela; Lombardi, Davide; De Giorgi, Ugo; Andreetta, Claudia; Cinieri, Saverio; De Angelis, Carmine; Priolo, Domenico; Casanova, Claudia; Rosati, Marta; Greco, Filippo; Zafarana, Elena; Schiavetto, Ilaria; Mammoliti... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review. (December 2021) Authors: Giudice, Elena; Salutari, Vanda; Ricci, Caterina; Nero, Camilla; Carbone, Maria Vittoria; Ghizzoni, Viola; Musacchio, Lucia; Landolfo, Chiara; Perri, Maria Teresa; Camarda, Floriana; Scambia, Giovanni; Lorusso, Domenica Journal: Critical reviews in oncology/hematology Issue: Volume 168(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. (November 2022) Authors: Musacchio, Lucia; Valsecchi, Anna Amela; Salutari, Vanda; Valabrega, Giorgio; Camarda, Floriana; Tuninetti, Valentina; Giannone, Gaia; Bartoletti, Michele; Marchetti, Claudia; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Di Maio, Massimo; Lorusso, Domenica Journal: Cancer treatment reviews Issue: Volume 110(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Recent progress in the use of pharmacotherapy for endometrial cancer. (2nd January 2023) Authors: Giudice, Elena; Salutari, Vanda; Ricci, Caterina; Nero, Camilla; Carbone, Maria Vittoria; Musacchio, Lucia; Ghizzoni, Viola; Perri, Maria Teresa; Camarda, Floriana; Tronconi, Francesca; Lorusso, Domenica; Scambia, Giovanni Journal: Expert opinion on pharmacotherapy Issue: Volume 24:Number 1(2023) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tisotumab Vedotin in Cervical Cancer: Current Status and Future Perspectives. Issue 2 (2021) Authors: Giudice, Elena; Musacchio, Lucia; Camarda, Floriana; Landolfo, Chiara; Salutari, Vanda Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TP003/#1533 MITO CERV3_phase II study on carboplatin-paclitaxel-pembrolizumab in neoadjuvant treatment of locally advanced cervical cancer. (4th December 2022) Authors: Salutari, Vanda; Camarda, Floriana; Musacchio, Lucia; Scalone, Simona; Savarese, Antonella; Gori, Stefania; Carbone, Maria Vittoria; Nero, Camilla; Vici, Patrizia; Bergamini, Alice; Zamagni, Claudio; Scambia, Giovanni; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TP033/#1441 MITO 25.1: a randomized, molecular driven phase II trial of carboplatin-paclitaxel-bevacizumab vs carboplatin-paclitaxel-bevacizumab-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer. (4th December 2022) Authors: Musacchio, Lucia; Salutari, Vanda; Pignata, Sandro; Valabrega, Giorgio; Zavallone, Laura; Cormio, Gennaro; Mosconi, Anna Maria; Giolitto, Serena; Camarda, Floriana; Ricci, Caterina; Zamagni, Claudio; Nero, Camilla; Carbone, Maria Vittoria; Ghizzoni, Viola; Sorio, Roberto; Salvatore, Siena; Tronco... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗